Keyphrases
Acid Activation
100%
Perfluoroalkyl Acids
100%
Lipid Homeostasis
100%
Liver Steatosis
100%
Peroxisome Proliferator-activated Receptor
63%
Perfluorohexanoic Acid (PFHxA)
54%
Null Mice
45%
Steatosis
45%
Liver
36%
Perfluorononanoic Acid
36%
Wild Mice
27%
Molecular Mechanism
18%
Lipid Metabolism
18%
Liver Lipid
18%
Liver Cells
9%
Rodents
9%
Transcriptional Activity
9%
Microarray Analysis
9%
Consumer Products
9%
Triglyceride Level
9%
Treatment Group
9%
Palmitoyl-CoA
9%
Acid Treatment
9%
L-carnitine
9%
Cell Size
9%
Lipid Accumulation
9%
DNA Content
9%
Triglyceride Synthesis
9%
Liver Weight
9%
Slow Decay
9%
Oral Gavage
9%
Fatty Acid Synthesis
9%
HepG2
9%
Rat Liver Mitochondria
9%
Human Liver Cells
9%
Peroxisome Proliferator-activated Receptor Agonists
9%
Hepatic Steatosis
9%
Biochemical Tests
9%
Fatty Acid Accumulation
9%
Isolated Rat Liver
9%
Industrial Products
9%
Liver Cell Culture
9%
Lipid Catabolism
9%
Oil Red O
9%
Persistent Presence
9%
Mitochondrial β-oxidation
9%
Fatty Acid β-oxidation
9%
Liver Accumulation
9%
WY14643
9%
In Vivo Oxidation
9%
Palmitate Oxidation
9%
Pharmacology, Toxicology and Pharmaceutical Science
Peroxisome Proliferator Activated Receptor
100%
Fatty Liver
100%
Steatosis
85%
Knockout Mouse
71%
Perfluorononanoic Acid
57%
Wild Type Mouse
42%
Perfluorooctanoic Acid
42%
Fatty Acid
42%
Triacylglycerol
42%
Perfluorohexanesulfonic Acid
42%
Cell Culture
14%
Palmitic Acid
14%
Palmitoylcarnitine
14%
PPAR Agonist
14%
Treatment Group
14%